Medical specialists from Netherlands tagged as investigators in clinical trials studying Hemophilia

Total 16 results

Floor Moenen, Dr, MD
Seen in:
- Limburg, Maastricht, Maastricht University Medical Center
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Karin P.M. van Galen, Dr, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Karina Meijer
Seen in:
- Groningen, University Medical Centre Groningen-UMCG
Trials:
- NCT04158934 (Principal Investigator)
Conditions:
- Hemophilia A
Kathelijn Fischer, Dr, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Principal Investigator)
Conditions:
Konrad van der Zwet, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Lize F.D. van Vulpen, Dr, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Louise Hooimeijer, MD
Seen in:
- Groningen, University Medical Center Groningen
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Marjon Cnossen, Dr. MD
Seen in:
- Zuid-Holland, Rotterdam, Erasmus University Medical Center
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Michiel Coppens, Dr, MD
Seen in:
- Noord-Holland, Amsterdam, Amsterdam University Medical Center
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Nanda Uitslager, Msc
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Paul den Exter, Dr, MD
Seen in:
- Zuid-Holland, Leiden, Leids Universitair Medisch Centrum
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Paul van der Valk, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Paula Ypma, MD
Seen in:
- Zuid-Holland, Den Haag, Hagaziekenhuis
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
Roger E.G. Schutgens, Prof, MD
Seen in:
- Utrecht, University Medical Center Utrecht
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:
S. Schols, MD PhD
Seen in:
- Nijmegen, Radboud University Medical Center
Trials:
- NCT03347591 (Principal Investigator)
- NCT06273865 (Principal Investigator)
Conditions:
- Rare Bleeding Disorders;
- Hemophilia A
Saskia Schols, Dr, MD
Seen in:
- Gelderland, Nijmegen, Radboud University Medical Center
Trials:
- NCT06320626 (Sub-Investigator)
Conditions:

Clinical Trials on Hemophilia

Nantes University Hospital

Completed

Gait Analysis in Moderate Hemophiliac Patients (AQM-Hemophile)

Arthropathy | Moderate Hemophilia

France
Catalyst Biosciences

Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Hemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without Inhibitor

Bulgaria, Russian Federation
Bayer

Completed

A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

Hemophilia A; Hemophilia B

Israel
GWT-TUD GmbH
Hannover Medical School; Hoffmann-La Roche

Completed

Emicizumab in Acquired Hemophilia A

Hemophilia A, Acquired

Austria, Germany
Pfizer

Completed

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Factor VIII Deficiency, Congenital | Hemophilia A, Congenital | Factor 8 Deficiency, Congenital | Autosomal Hemophilia A | Classic Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies
LFB USA, Inc.

Completed

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (PERSEPT2)

Hemophilia A With Inhibitors | Hemophilia B With Inhibitors

Bulgaria, Ukraine, Czechia, United States, Georgia, South Africa
University College, London

Recruiting

Liver Biopsy In Haemophilia Gene Therapy

Hemophilia A, Severe | Hemophilia B, Severe

United Kingdom
University of British Columbia
Biogen

Completed

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Hemophilia A, Congenital | Hemophilia B, Congenital

Canada
Catalyst Biosciences

Completed

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Hemophilia A With Inhibitor | Hemophilia B With Inhibitor

Armenia, Georgia, South Africa, Poland, Russian Federation
CSL Behring

Terminated

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

Hemophilia A With Inhibitors | Hemophilia B With Inhibitors

Georgia, Italy, Malaysia, Russian Federation, South Africa, Spain, Thailand, Ukraine, United Kingdom

Medical specialists from Netherlands tagged as investigators in clinical trials studying Hemophilia

Clinical Trials on Hemophilia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations